- In May 2024, Meatly announced the development of a new protein-free culture medium priced at just one pound. This innovation aims to dramatically cut production costs, making cultured meat more affordable for mass-market retail, especially supermarkets. By enhancing cost-efficiency, Meatly moves closer to achieving price parity with conventional meat. The development also supports scalability and strengthens Meatly's market position. It marks a significant step toward mainstream cultured meat adoption
- In September 2023, Eat Just Inc. entered a strategic partnership with the Halal Products Development Company (HPDC), owned by Saudi Arabia’s Public Investment Fund. The collaboration focuses on securing Halal certification and regulatory approvals for Eat Just’s products. HPDC will also guide Eat Just in forming a long-term Halal market entry strategy. This move supports the company’s ambition to serve local and regional markets. It opens a new growth channel in the Muslim-majority consumer base
- In April 2023, BlueNalu signed a Letter of Intent (LOI) with Nutreco to advance the supply chain for cell-cultured seafood. This is the third agreement between the two companies, following previous collaborations and Nutreco’s Series A investment. The LOI aims to reduce cell feed costs and define material specifications. It supports BlueNalu's shift from pilot phase to commercialization. This partnership strengthens efforts toward scalable, cost-effective cultured seafood production
- In November 2022, Mosa Meat entered a market access agreement with Singapore-based Esco Aster to introduce its cultivated beef to Singapore. This deal gives Mosa Meat a strategic entry into one of the most supportive regulatory markets for cultured meat. Singapore’s openness to food tech innovation offers a first-mover advantage. The partnership also positions Mosa Meat for broader global expansion. It underscores Singapore’s role as a launchpad for future food technologies
- In April 2022, Upside Foods raised USD 400 million in Series C funding to support the next phase of its growth. The funds will be used to build a commercial-scale facility, educate consumers, and develop a reliable, affordable supply chain for cell feed. This investment marks one of the largest in the cultured meat sector. It accelerates Upside’s path to large-scale production and market entry. The funding reinforces investor confidence in the future of cultivated meat
